ProAssurance (PRA) to Release Earnings on Monday

ProAssurance (NYSE:PRA) is expected to be issuing its quarterly earnings data after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of $0.17 per share and revenue of $274.56 million for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

ProAssurance Trading Down 2.9 %

ProAssurance stock opened at $13.99 on Friday. The company has a 50 day moving average price of $15.19 and a 200 day moving average price of $14.98. ProAssurance has a 52 week low of $10.76 and a 52 week high of $17.79. The company has a debt-to-equity ratio of 0.35, a quick ratio of 0.28 and a current ratio of 0.28. The firm has a market capitalization of $715.42 million, a price-to-earnings ratio of 16.85 and a beta of 0.27.

Wall Street Analysts Forecast Growth

PRA has been the subject of a number of recent analyst reports. Piper Sandler lowered shares of ProAssurance from an “overweight” rating to a “neutral” rating and set a $18.00 price objective for the company. in a research note on Monday, November 11th. Truist Financial raised their price objective on shares of ProAssurance from $14.00 to $18.00 and gave the stock a “hold” rating in a research note on Tuesday, November 12th. Finally, StockNews.com raised shares of ProAssurance from a “hold” rating to a “buy” rating in a research note on Thursday, December 26th.

ProAssurance Company Profile

ProAssurance Corporation, through its subsidiaries, provides property and casualty insurance, and reinsurance products in the United States. The company operates through Specialty Property and Casualty, Workers’ Compensation Insurance, and Segregated Portfolio Cell Reinsurance segments. It offers professional liability insurance to healthcare providers and institutions, and attorneys and their firms; medical technology liability insurance to medical technology and life sciences companies; and custom alternative risk solutions, including assumed reinsurance, loss portfolio transfers, and captive cell programs for healthcare professional liability insureds.